Entera Bio Ltd (ENTX)

Nov 20, 2024

Knoll Capital Management, LLC's Strategic Acquisition in Entera Bio Ltd - GuruFocus.com

Nov 20, 2024

Nov 17, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat

Nov 17, 2024

Nov 14, 2024

FY2024 EPS Estimate for Entera Bio Decreased by Analyst - MarketBeat

Nov 14, 2024

Nov 11, 2024

HC Wainwright Reaffirms Buy Rating for Entera Bio (NASDAQ:ENTX) - MarketBeat

Nov 11, 2024

Nov 08, 2024

Entera Bio Ltd. (ENTX) Quarterly 10-Q Report - Quartzy

Nov 08, 2024

Nov 08, 2024

Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Entera Bio Highlights Q3 2024 Financials and FDA Anticipation - TipRanks

Nov 08, 2024

Nov 08, 2024

Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates - The Manila Times

Nov 08, 2024

Oct 29, 2024

Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Drops By 14.4% - MarketBeat

Oct 29, 2024

Oct 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 38.4% in September - MarketBeat

Oct 13, 2024

Oct 07, 2024

Entera Bio outlook steady as H.C. Wainwright backs potential of total hip BMD in osteoporosis care - Investing.com Australia

Oct 07, 2024

Oct 07, 2024

Entera Bio (NASDAQ:ENTX) Rating Reiterated by HC Wainwright - MarketBeat

Oct 07, 2024

Oct 04, 2024

Are Medical Stocks Lagging Argenx (ARGX) This Year? - Yahoo Finance

Oct 04, 2024

Sep 30, 2024

ENTX & OPK Stock May Gain Following Positive PK/PD Research Data - MSN

Sep 30, 2024

Sep 29, 2024

Entera Bio shares hold Buy rating on OXM study success By Investing.com - Investing.com Australia

Sep 29, 2024

Sep 28, 2024

Entera Bio shares hold Buy rating on OXM study success - Investing.com

Sep 28, 2024

Sep 27, 2024

Entera Bio's (ENTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Sep 27, 2024

Sep 26, 2024

Entera Bio and OPKO Health report promising obesity treatment study By Investing.com - Investing.com Australia

Sep 26, 2024

Sep 25, 2024

Entera Bio and OPKO Health report promising obesity treatment study - Investing.com

Sep 25, 2024

Sep 25, 2024

Entera Bio And Opko Health Provide Update On Pk/Pd Results Of Oral Oxyntomodulin (Glp-1/Glucagon) Peptide Tablet Candidate For Obesity And Metabolic Disorders - XM

Sep 25, 2024

Sep 25, 2024

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide - EIN News

Sep 25, 2024

Sep 25, 2024

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders - Yahoo Canada Finance

Sep 25, 2024

Sep 20, 2024

Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year? - MSN

Sep 20, 2024

Sep 03, 2024

Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? - MSN

Sep 03, 2024

Sep 01, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest - MarketBeat

Sep 01, 2024

Aug 30, 2024

We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate - Yahoo Finance

Aug 30, 2024

Aug 20, 2024

Entera Bio to Participate in Upcoming Investor and Scientific Conferences - GlobeNewswire

Aug 20, 2024

Aug 15, 2024

All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy - Yahoo Finance

Aug 15, 2024

Aug 15, 2024

Entera Bio Ltd. Forecasted to Earn Q3 2024 Earnings of ($0.05) Per Share (NASDAQ:ENTX) - Defense World

Aug 15, 2024

Aug 15, 2024

Entera Bio Ltd. to Post Q3 2024 Earnings of ($0.05) Per Share, HC Wainwright Forecasts (NASDAQ:ENTX) - MarketBeat

Aug 15, 2024

Aug 13, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 51.0% in July - MarketBeat

Aug 13, 2024

Aug 12, 2024

Entera Bio (NASDAQ:ENTX) Releases Earnings Results - MarketBeat

Aug 12, 2024

Aug 12, 2024

Entera Bio's (ENTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Aug 12, 2024

Aug 12, 2024

HC Wainwright Reiterates Buy Rating for Entera Bio (NASDAQ:ENTX) - Defense World

Aug 12, 2024

Aug 09, 2024

Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates - GlobeNewswire

Aug 09, 2024

Aug 09, 2024

Virtu Financial LLC Invests $37,000 in Entera Bio Ltd. (NASDAQ:ENTX) - Defense World

Aug 09, 2024

Aug 07, 2024

Entera Bio Ltd expected to post a loss of 6 cents a shareEarnings Preview - XM

Aug 07, 2024

Aug 06, 2024

The 10 Best Biotech Stocks Under $5 To Buy For September 2024! - The Stock Dork

Aug 06, 2024

Aug 02, 2024

Entera Bio shareholders approve executive compensation, board appointments - Investing.com

Aug 02, 2024

Aug 01, 2024

Entera’s EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual MeetingKey SABRE Update Also Expected - StockTitan

Aug 01, 2024

Aug 01, 2024

Entera Bio (NASDAQ:ENTX) Trading Up 1.9% - MarketBeat

Aug 01, 2024

Aug 01, 2024

Entera Bio (NASDAQ:ENTX) Stock Price Up 1.9% - Defense World

Aug 01, 2024

Jul 28, 2024

Entera Bio (NASDAQ:ENTX) & Vericel (NASDAQ:VCEL) Financial Survey - Defense World

Jul 28, 2024

Jul 27, 2024

Short bowel syndrome Market Positive Outlook: Phase Bio , Orphan Technologies , Zealand Pharma - Newstrail

Jul 27, 2024

Jul 23, 2024

3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years - Markets Insider

Jul 23, 2024